CTDHoldings 24st Centry Investments Cydodextrins
  • Home
  • Company Info
    • Overview
    • Management Team
    • Board of Directors
    • Mission & Vision
  • Cyclodextrins
    • Trappsol® Cyclo™
    • Trappsol®
    • Aquaplex®
    • Applications
  • Subsidiaries
    • Sphingo Biotechnology, Inc.
    • CTD, Inc.
  • Our Business
    • Cyclodextrin Market
    • Competitive Analysis
    • Business Strategy
  • Media Center
    • Company News
  • Investors
    • News / Events
      • Company News
      • In The News
      • Presentations
      • Email Alerts
    • Company Information
      • Profile
      • Management Team
      • IR Contacts
      • FAQ
    • Financial Information
      • Financials
    • Stock Information
      • Quote
      • Charts
      • Historical Quotes
    • SEC Filings
      • All SEC Filings
      • Insiders
    • Corporate Governance
      • Board of Directors
  • Contact Us
 

Company News

  • Home
  • Investors
  • News / Events
  • Company News
  • All News
  • By Year:
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease
    Aug 13, 2018, 8:00 AM EDT
  • CTD is working to establish a second clinical trial site at Morristown Medical Center, Atlantic Health System, Morristown, NJ
    Aug 6, 2018, 8:00 AM EDT
  • CTD to Present at National Niemann-Pick Disease Foundation Annual Conference
    Jun 27, 2018, 8:00 AM EDT
  • FDA Authorizes CTD to Proceed with Extension Protocol to US Phase I Trappsol(R) Cyclo(TM) Trial for Niemann-Pick Disease Type C
    Apr 30, 2018, 8:00 AM EDT
  • CTD Holdings Closes $2.00 Million Private Placement
    Apr 23, 2018, 8:00 AM EDT
  • CTD Holdings Finalizes Cooperative Agreement for Alzheimer's Disease Research Program
    Apr 19, 2018, 8:00 AM EDT
  • CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C
    Mar 29, 2018, 1:45 PM EDT
  • Randall M. Toig, M.D. Joins CTD Holdings Board of Directors
    Mar 20, 2018, 8:00 AM EDT
  • CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) Cyclo(TM) to Treat Alzheimer's Disease
    Mar 12, 2018, 9:04 AM EDT
  • CTD Holdings Initiates Research Program to Explore Cyclodextrin Therapy for Alzheimer's Disease
    Jan 29, 2018, 8:00 AM EST
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...13
  • Next >>
Show All
  • News / Events
    • Company News
    • In The News
    • Presentations
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Information
  • SEC Filings
  • Corporate Governance

Links

  • Home
  • Cyclodex
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
  • Sitemap
  • Contact Us

Investor Quicklinks

  • image description
    IR Overview
  • image description
    IR Contacts
  • image description
    IR FAQ
  • image description
    News/Events
  • image description
    Financial Info
  • image description
    SEC Filing
  • image description
    Corporate Governance
  • image description
    Stock Info

Connect With Us

  • rss
  • youtube
  • mail
© Copyright 2019 CTD Holdings, Inc. All Rights Reserved. Website by Equisolve